Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
ATLANTA, Feb. 29, 2024 /PRNewswire/ -- The American Most cancers Society (ACS) and the Colorectal Most cancers Alliance (Alliance) are becoming a member of forces on...
